Target intelligence / Profile preview

Novel transcript, antisense to Triadin (TRDN-AS)

Target
TRDN-AS
Molecular classification
Long non-coding RNA (lncRNA), Other (non-coding RNA)
01

Overview

This target is a long non-coding RNA transcript antisense to the TRDN (Triadin) gene, known as ENSG00000285691 in the Ensembl database. It does not encode a protein and is not a classical molecular target. Antisense transcripts may modulate gene expression of their sense counterparts; in the mouse, a similar transcript (TRDN-AS) helps regulate the ratio of cardiac and skeletal isoforms of Triadin, which is critical for calcium signaling in muscle tissue. No direct disease role, drug interactions, or biomarker status is established for the human transcript, but its location raises the possibility of regulatory roles affecting TRDN, itself important in cardiovascular and muscular disease.

Other names
Novel transcript, antisense to TRDNTRDN antisense RNATRDN-AS
02

Biological functions

Putative gene regulatory function (may regulate balance between cardiac and skeletal isoforms of Triadin in the mouse, possibly similar in human, but specific biological functions in humans remain unclear)
03

Disease associations

Other (no direct disease association established; might regulate Triadin, which is implicated in arrhythmia and muscular disease)

Beyond the preview

Go deeper on Novel transcript, antisense to Triadin (TRDN-AS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to Triadin (TRDN-AS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call